ASTRIA THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the 2027 annual meeting of stockholders: Gregg Lapointe

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gregg Lapointe”): 38,546,969 for, 7,366,654 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 10,246,275 for, 2,067,045 withheld.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the 2027 annual meeting of stockholders: Jonathan Violin

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jonathan Violin”): 39,155,703 for, 6,757,920 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 10,327,506 for, 1,985,814 withheld.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: The election of three Class III Directors to our Board of Directors, to serve for a three-year term until the 2027 annual meeting of stockholders: Sunil Agarwal

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sunil Agarwal”): 46,212,531 for, 23,723 withheld, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 12,313,320 for.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: THE APPROVAL OF THE SECOND AMENDMENT AND RESTATEMENT OF OUR AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, AS AMENDED, TO, AMONG OTHER THINGS, INCREASE THE NUMBER OF SHARES OF OUR COMMON STOCK AVAILABLE FOR GRANT UNDER THE PLAN BY 5,750,000 SHARES AND EXTEND THE TERM OF THE PLAN TO TEN YEARS FROM THE DATE SUCH SECOND AMENDMENT AND RESTATEMENT IS APPROVED BY OUR STOCKHOLDERS.

ASTRIA THERAPEUTICS INC.’s own tally for this item (“2. The Second Amended and Restated 2015 Plan, to, among other things, increase the number of shares of common stock available for grant under the 2015 Plan by 5,750,000 shares, and extend t”): 33,617,011 for, 12,637,381 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders of the Company approved the Second Amended and Restated 2015 Plan, to, among other things, increase the number of shares of common stock available for grant under the 2015 Plan by 5,750,000 shares, and extend t”
Support: 73% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 5,292,537 for, 7,020,783 against.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION.

ASTRIA THERAPEUTICS INC.’s own tally for this item (“4. The compensation of the Company's named executive officers”): 40,882,888 for, 5,346,924 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of ASTRIA THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (2 managers, 1,540,936 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 44 managers: 11,341,001 for, 972,319 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 96 managers: 33,469,557 for, 3,519,545 against, 111 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.

ASTRIA THERAPEUTICS INC.’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 51,069,770 for, 32,061 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 12,311,134 for, 2,186 against.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.